United States
Germany
Japan
United Kingdom
China
BRCA2 (tGFP-tagged) - Human breast cancer 2, early onset (BRCA2)
| Type | Human Tagged ORF Clone |
| Tag | TurboGFP |
| Vector | pCMV6-AC-GFP |
- TrueORF®
Products
BRCA2 (Myc-DDK-tagged)-Human breast cancer 2, early onset (BRCA2)
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
Brca2 (myc-DDK-tagged) - Mouse breast cancer 2 (Brca2), transcript variant 1
| Type | Mouse Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
Brca2 (tGFP-tagged) - Mouse breast cancer 2 (Brca2) transcript variant 2, (10ug)
| Type | Mouse Tagged ORF Clone |
| Tag | TurboGFP |
| Vector | pCMV6-AC-GFP |
- TrueORF®
Brca2 (Myc-DDK-tagged) - Mouse breast cancer 2 (Brca2), transcript variant 2
| Type | Mouse Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
BRCA2 Mutant (H2074N), Myc-DDK-tagged ORF clone of Homo sapiens breast Cancer, early onset (BRCA2) as transfection-ready DNA
| Mutation | H2074N |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
BRCA2 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pGFP-V-RS |
BRCA2 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRS |
Brca2 - Mouse, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pGFP-V-RS |
BRCA2 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
